A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

Zunveyl is a next-generation acetylcholinesterase inhibitor approved in the U.S. for mild-to-moderate Alzheimer's disease.

Johnson & Johnson on Wednesday said it has won Food and Drug Administration fast-track designation for its proposed posdinemab treatment for Alzheimer's disease. J&J is investigating the internally ...

Learn how targeted hip-opening exercises can boost flexibility, reduce chronic pain, and improve mobility patterns for better ...

The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...